Sutter Health Research Enterprise
1501 Trousdale Drive
Building B, Floor 4
Burlingame, CA, 94010
(650) 652-8350
Brajesh.Agrawal@sutterhealth.org
Primary Research Interests
Related Clinical Trials
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease
Investigators: Brajesh Agrawal MD, Minal Bhanushali MD, PAMFRI Medical Director
Status: Active, Recruiting